๐ Safety Assurance: Regulatory Compliance and Outsourcing in the Pharmacovigilance Market
The Pharmacovigilance (PV) Market is a critical regulatory function within the pharmaceutical and biotechnology industries, involving the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems throughout the lifecycle of a medicinal product. The increasing complexity and globalization of drug development and regulatory requirements (e.g., $\text{ICH}$ guidelines) are key market drivers.
The global compliance demands efficiently and cost-effectively, defining the growth trajectory of the specialized Pharmacovigilance Market.
A significant trend is the rise in PV Outsourcing, where pharmaceutical companies, particularly small and mid-sized firms, contract specialized services to Clinical Research Organizations ($\text{CROs}$) or dedicated $\text{PV}$ service providers. Outsourced services range from case processing, safety data management (ICSRs), signal detection, and aggregate report writing (e.g., PSURs) to full end-to-end $\text{PV}$ system management. The demand for highly specialized, flexible staffing models and advanced Safety Database Technologies is necessary to meet
Related Reports